Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...

Burning fossil fuels has led to a global energy crisis, worsening pollution and climate change. To tackle this problem, we ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Thermo Fisher is a Life Sciences giant with over $42 billion in yearly revenues and 120 thousand employees. Find out why I ...

Introduction An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are cl ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...

Authenticated data presented in the Life science tools market report is based on findings of extensive primary and secondary research.

The immuno-oncology assay market is driven by the growing adoption of cancer immunotherapy, which has revolutionized cancer treatment by harnessing the body’s immune system to target and destroy ...

NGS, flow cytometry, and ISH based on technology. In 2020, the NGS segment accounted for the highest growth rate. Factors such as the launch of new and advanced products, decreased cost of ...